CDXS · Codexis, Inc.
$1.45
+0.02 (+1.40%)
At close · Aug 5
Market Cap
$131.35M
Shares
90.90M
Codexis, Inc. Earnings Call Transcripts
Every quarterly earnings call for Codexis, Inc. (CDXS) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲96%
$35.34M
−$8.36M
'22 Q1
22-05-05
▲50.9%
$38.41M
−$2.64M
'22 Q2
22-08-04
▼6.3%
$34.47M
−$9.99M
'22 Q3
22-11-03
▲24%
$30.37M
−$12.60M
'22 Q4
23-02-23
▼73.1%
$9.28M
−$34.91M
'23 Q3
23-11-02
▼12.6%
$26.56M
−$7.19M
'23 Q4
24-02-28
▲31.5%
$17.07M
−$11.51M
'24 Q1
24-05-02
▼62.6%
$7.98M
−$22.75M
'24 Q2
24-08-08
▲38.3%
$12.83M
−$20.64M
'24 Q3
24-10-31
▼19.2%
$21.46M
−$10.38M
'24 Q4
25-02-27
▼55.8%
$7.54M
−$20.69M
'25 Q1
25-05-14
▲92.1%
$15.33M
−$13.27M
'25 Q2
25-08-13
▼33%
$8.60M
−$19.61M
'25 Q3
25-11-06
▲81.3%
$38.91M
$9.60M
'25 Q4
26-03-11
LATEST
▲102.1%
$15.25M
−$8.70M
'26 Q1
26-05-07
Earnings call
FY26 · Q2
2026-07-23
Q2 2026 Codexis, Inc. Earnings Conference Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-06-17
2026 Annual Meeting of Stockholders
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-07
Codexis, Inc. Q1 FY2026 Earnings Call
Confident tone
Ecosynthesis platform progress
CDMO partnerships and licensing deals
Stereoisomer control capability
Revenue
$15.25M
▲ 102.1% YoY Diluted EPS
$-0.10
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-11
Codexis, Inc. Q4 FY2025 Earnings Call
Confident tone
ECOsynthesis platform progress and scaling
siRNA market opportunity and demand
Commercial partnerships and CDMO agreements
Revenue
$38.91M*
▲ 81.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-03-03
TD Cowen 46th Annual Health Care Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-11-06
Codexis, Inc. Q3 FY2025 Earnings Call
Confident tone
ECO Synthesis Platform / siRNA Manufacturing
Leadership Transition / Organizational Restructuring
Merck Supply Assurance Agreement
Revenue
$8.60M
▼ 33% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Codexis, Inc. Q2 FY2025 Earnings Call
Confident tone
ECO Synthesis platform momentum
Customer engagements and pipeline
Financial performance and guidance
Revenue
$15.33M
▲ 92.1% YoY Diluted EPS
$-0.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Codexis, Inc. Q1 FY2025 Earnings Call
Confident tone
TIDES USA Presentations / CDMO Collaborators
Ligase Business Growth
siRNA Industry Momentum
Revenue
$7.54M
▼ 55.8% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Codexis, Inc. Q4 FY2024 Earnings Call
Confident tone
ECO Synthesis commercial launch
Customer engagement and partnerships
GMP manufacturing and scale-up
Revenue
$21.46M*
▼ 19.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-31
Codexis, Inc. Q3 FY2024 Earnings Call
Confident tone
ECO Synthesis Manufacturing Platform
Double-Stranded RNA Ligase
Nucleotide Building Blocks (NQP/NTP)
Revenue
$12.83M
▲ 38.3% YoY Diluted EPS
$-0.29
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Codexis, Inc. Q2 FY2024 Earnings Call
Confident tone
ECO Synthesis Platform
Pharma Manufacturing Business
Double-Stranded RNA Ligase
Revenue
$7.98M
▼ 62.6% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Codexis, Inc. Q1 FY2024 Earnings Call
Confident tone
Double-Stranded RNA Ligase Program and Screening Service
Pharma Manufacturing Customer Base and Diversification
2024 Financial Guidance Reiteration
Revenue
$17.07M
▲ 31.5% YoY Diluted EPS
$-0.16
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-28
Codexis, Inc. Q4 FY2023 Earnings Call
Confident tone
RNA ligase (dsRNA) commercial opportunity
Strategic licensing and partnerships
ECO Synthesis manufacturing platform
Revenue
$26.56M*
▼ 12.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Codexis, Inc. Q3 FY2023 Earnings Call
Revenue
$9.28M
▼ 73.1% YoY Diluted EPS
$-0.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-23
Codexis, Inc. Q4 FY2022 Earnings Call
Revenue
$30.37M*
▲ 24% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Codexis, Inc. Q3 FY2022 Earnings Call
Revenue
$34.47M
▼ 6.3% YoY Diluted EPS
$-0.15
▼ 600% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Codexis, Inc. Q2 FY2022 Earnings Call
Revenue
$38.41M
▲ 50.9% YoY Diluted EPS
$-0.04
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Codexis, Inc. Q1 FY2022 Earnings Call
Revenue
$35.34M
▲ 96% YoY Diluted EPS
$-0.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Codexis, Inc. Q4 FY2021 Earnings Call
Revenue
$24.50M*
▲ 16.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Codexis, Inc. Q3 FY2021 Earnings Call
Revenue
$36.77M
▲ 100% YoY Diluted EPS
$0.03
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Codexis, Inc. Q2 FY2021 Earnings Call
Revenue
$25.45M
▲ 70.1% YoY Diluted EPS
$-0.07
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-06
Codexis, Inc. Q1 FY2021 Earnings Call
Revenue
$18.03M
▲ 22.9% YoY Diluted EPS
$-0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-25
Codexis, Inc. Q4 FY2020 Earnings Call
Revenue
$21.03M*
▲ 12.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Codexis, Inc. Q3 FY2020 Earnings Call
Revenue
$18.39M
▼ 16.1% YoY Diluted EPS
$-0.10
▼ 1100% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-06
Codexis, Inc. Q2 FY2020 Earnings Call
Revenue
$14.97M
▲ 21.5% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Codexis, Inc. Q1 FY2020 Earnings Call
Revenue
$14.67M
▼ 5.9% YoY Diluted EPS
$-0.13
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Codexis, Inc. Q4 FY2019 Earnings Call
Revenue
$18.65M*
▲ 16.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–27 of 27 earnings calls
Key facts
CIK
1200375
CUSIP
192005106
13F (30d)
33 filings
32 filers
Visit website
Investor relations